Global Peripheral Intervention Drug-Eluting Devices Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Peripheral Intervention Drug-Eluting Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Peripheral Intervention Drug-Eluting Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Peripheral Intervention Drug-Eluting Devices market. Peripheral Intervention Drug-Eluting Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peripheral Intervention Drug-Eluting Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peripheral Intervention Drug-Eluting Devices market.
Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Peripheral Intervention Drug-Eluting Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peripheral Intervention Drug-Eluting Devices market. It may include historical data, market segmentation by Type (e.g., Drug-Eluting Balloons, Drug-Eluting Stents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peripheral Intervention Drug-Eluting Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peripheral Intervention Drug-Eluting Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peripheral Intervention Drug-Eluting Devices industry. This include advancements in Peripheral Intervention Drug-Eluting Devices technology, Peripheral Intervention Drug-Eluting Devices new entrants, Peripheral Intervention Drug-Eluting Devices new investment, and other innovations that are shaping the future of Peripheral Intervention Drug-Eluting Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peripheral Intervention Drug-Eluting Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Peripheral Intervention Drug-Eluting Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peripheral Intervention Drug-Eluting Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peripheral Intervention Drug-Eluting Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peripheral Intervention Drug-Eluting Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peripheral Intervention Drug-Eluting Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peripheral Intervention Drug-Eluting Devices market.
Market Segmentation:
Peripheral Intervention Drug-Eluting Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Peripheral Intervention Drug-Eluting Devices market?
What factors are driving Peripheral Intervention Drug-Eluting Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peripheral Intervention Drug-Eluting Devices market opportunities vary by end market size?
How does Peripheral Intervention Drug-Eluting Devices break out type, application?
According to our LPI (LP Information) latest study, the global Peripheral Intervention Drug-Eluting Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Peripheral Intervention Drug-Eluting Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Peripheral Intervention Drug-Eluting Devices market. Peripheral Intervention Drug-Eluting Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peripheral Intervention Drug-Eluting Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peripheral Intervention Drug-Eluting Devices market.
Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Peripheral Intervention Drug-Eluting Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peripheral Intervention Drug-Eluting Devices market. It may include historical data, market segmentation by Type (e.g., Drug-Eluting Balloons, Drug-Eluting Stents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peripheral Intervention Drug-Eluting Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peripheral Intervention Drug-Eluting Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peripheral Intervention Drug-Eluting Devices industry. This include advancements in Peripheral Intervention Drug-Eluting Devices technology, Peripheral Intervention Drug-Eluting Devices new entrants, Peripheral Intervention Drug-Eluting Devices new investment, and other innovations that are shaping the future of Peripheral Intervention Drug-Eluting Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peripheral Intervention Drug-Eluting Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Peripheral Intervention Drug-Eluting Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peripheral Intervention Drug-Eluting Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peripheral Intervention Drug-Eluting Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peripheral Intervention Drug-Eluting Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peripheral Intervention Drug-Eluting Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peripheral Intervention Drug-Eluting Devices market.
Market Segmentation:
Peripheral Intervention Drug-Eluting Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Drug-Eluting Balloons
- Drug-Eluting Stents
- Plain Old Balloon Angioplasty (POBA)
- Percutaneous Transluminal Angioplasty (PTA)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Cardinal Health
- B. Braun Melsungen AG
- Biosensors International Group Ltd.
- C.R. Bard, Inc.
- Abbott
- The Lubrizol Corporation
- Terumo Corporation
What is the 10-year outlook for the global Peripheral Intervention Drug-Eluting Devices market?
What factors are driving Peripheral Intervention Drug-Eluting Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peripheral Intervention Drug-Eluting Devices market opportunities vary by end market size?
How does Peripheral Intervention Drug-Eluting Devices break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Peripheral Intervention Drug-Eluting Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Peripheral Intervention Drug-Eluting Devices by Country/Region, 2019, 2023 & 2030
2.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
2.2.1 Drug-Eluting Balloons
2.2.2 Drug-Eluting Stents
2.3 Peripheral Intervention Drug-Eluting Devices Sales by Type
2.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Type (2019-2024)
2.4 Peripheral Intervention Drug-Eluting Devices Segment by Application
2.4.1 Plain Old Balloon Angioplasty (POBA)
2.4.2 Percutaneous Transluminal Angioplasty (PTA)
2.5 Peripheral Intervention Drug-Eluting Devices Sales by Application
2.5.1 Global Peripheral Intervention Drug-Eluting Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Application (2019-2024)
3 GLOBAL PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES BY COMPANY
3.1 Global Peripheral Intervention Drug-Eluting Devices Breakdown Data by Company
3.1.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales by Company (2019-2024)
3.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2019-2024)
3.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Company (2019-2024)
3.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2019-2024)
3.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Company
3.4 Key Manufacturers Peripheral Intervention Drug-Eluting Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peripheral Intervention Drug-Eluting Devices Product Location Distribution
3.4.2 Players Peripheral Intervention Drug-Eluting Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Peripheral Intervention Drug-Eluting Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Peripheral Intervention Drug-Eluting Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Peripheral Intervention Drug-Eluting Devices Sales Growth
4.4 APAC Peripheral Intervention Drug-Eluting Devices Sales Growth
4.5 Europe Peripheral Intervention Drug-Eluting Devices Sales Growth
4.6 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Growth
5 AMERICAS
5.1 Americas Peripheral Intervention Drug-Eluting Devices Sales by Country
5.1.1 Americas Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024)
5.1.2 Americas Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024)
5.2 Americas Peripheral Intervention Drug-Eluting Devices Sales by Type
5.3 Americas Peripheral Intervention Drug-Eluting Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Intervention Drug-Eluting Devices Sales by Region
6.1.1 APAC Peripheral Intervention Drug-Eluting Devices Sales by Region (2019-2024)
6.1.2 APAC Peripheral Intervention Drug-Eluting Devices Revenue by Region (2019-2024)
6.2 APAC Peripheral Intervention Drug-Eluting Devices Sales by Type
6.3 APAC Peripheral Intervention Drug-Eluting Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peripheral Intervention Drug-Eluting Devices by Country
7.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024)
7.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024)
7.2 Europe Peripheral Intervention Drug-Eluting Devices Sales by Type
7.3 Europe Peripheral Intervention Drug-Eluting Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices by Country
8.1.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type
8.3 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peripheral Intervention Drug-Eluting Devices
10.3 Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
10.4 Industry Chain Structure of Peripheral Intervention Drug-Eluting Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peripheral Intervention Drug-Eluting Devices Distributors
11.3 Peripheral Intervention Drug-Eluting Devices Customer
12 WORLD FORECAST REVIEW FOR PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES BY GEOGRAPHIC REGION
12.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Forecast by Region
12.1.1 Global Peripheral Intervention Drug-Eluting Devices Forecast by Region (2025-2030)
12.1.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Peripheral Intervention Drug-Eluting Devices Forecast by Type
12.7 Global Peripheral Intervention Drug-Eluting Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic plc
13.1.1 Medtronic plc Company Information
13.1.2 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic plc Main Business Overview
13.1.5 Medtronic plc Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Cardinal Health
13.4.1 Cardinal Health Company Information
13.4.2 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Cardinal Health Main Business Overview
13.4.5 Cardinal Health Latest Developments
13.5 B. Braun Melsungen AG
13.5.1 B. Braun Melsungen AG Company Information
13.5.2 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 B. Braun Melsungen AG Main Business Overview
13.5.5 B. Braun Melsungen AG Latest Developments
13.6 Biosensors International Group Ltd.
13.6.1 Biosensors International Group Ltd. Company Information
13.6.2 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Biosensors International Group Ltd. Main Business Overview
13.6.5 Biosensors International Group Ltd. Latest Developments
13.7 C.R. Bard, Inc.
13.7.1 C.R. Bard, Inc. Company Information
13.7.2 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 C.R. Bard, Inc. Main Business Overview
13.7.5 C.R. Bard, Inc. Latest Developments
13.8 Abbott
13.8.1 Abbott Company Information
13.8.2 Abbott Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Abbott Main Business Overview
13.8.5 Abbott Latest Developments
13.9 The Lubrizol Corporation
13.9.1 The Lubrizol Corporation Company Information
13.9.2 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 The Lubrizol Corporation Main Business Overview
13.9.5 The Lubrizol Corporation Latest Developments
13.10 Terumo Corporation
13.10.1 Terumo Corporation Company Information
13.10.2 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Terumo Corporation Main Business Overview
13.10.5 Terumo Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Peripheral Intervention Drug-Eluting Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Peripheral Intervention Drug-Eluting Devices by Country/Region, 2019, 2023 & 2030
2.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
2.2.1 Drug-Eluting Balloons
2.2.2 Drug-Eluting Stents
2.3 Peripheral Intervention Drug-Eluting Devices Sales by Type
2.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Type (2019-2024)
2.4 Peripheral Intervention Drug-Eluting Devices Segment by Application
2.4.1 Plain Old Balloon Angioplasty (POBA)
2.4.2 Percutaneous Transluminal Angioplasty (PTA)
2.5 Peripheral Intervention Drug-Eluting Devices Sales by Application
2.5.1 Global Peripheral Intervention Drug-Eluting Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Application (2019-2024)
3 GLOBAL PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES BY COMPANY
3.1 Global Peripheral Intervention Drug-Eluting Devices Breakdown Data by Company
3.1.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales by Company (2019-2024)
3.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2019-2024)
3.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Company (2019-2024)
3.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2019-2024)
3.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Company
3.4 Key Manufacturers Peripheral Intervention Drug-Eluting Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peripheral Intervention Drug-Eluting Devices Product Location Distribution
3.4.2 Players Peripheral Intervention Drug-Eluting Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Peripheral Intervention Drug-Eluting Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Peripheral Intervention Drug-Eluting Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Peripheral Intervention Drug-Eluting Devices Sales Growth
4.4 APAC Peripheral Intervention Drug-Eluting Devices Sales Growth
4.5 Europe Peripheral Intervention Drug-Eluting Devices Sales Growth
4.6 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Growth
5 AMERICAS
5.1 Americas Peripheral Intervention Drug-Eluting Devices Sales by Country
5.1.1 Americas Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024)
5.1.2 Americas Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024)
5.2 Americas Peripheral Intervention Drug-Eluting Devices Sales by Type
5.3 Americas Peripheral Intervention Drug-Eluting Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Intervention Drug-Eluting Devices Sales by Region
6.1.1 APAC Peripheral Intervention Drug-Eluting Devices Sales by Region (2019-2024)
6.1.2 APAC Peripheral Intervention Drug-Eluting Devices Revenue by Region (2019-2024)
6.2 APAC Peripheral Intervention Drug-Eluting Devices Sales by Type
6.3 APAC Peripheral Intervention Drug-Eluting Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peripheral Intervention Drug-Eluting Devices by Country
7.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024)
7.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024)
7.2 Europe Peripheral Intervention Drug-Eluting Devices Sales by Type
7.3 Europe Peripheral Intervention Drug-Eluting Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices by Country
8.1.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type
8.3 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peripheral Intervention Drug-Eluting Devices
10.3 Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
10.4 Industry Chain Structure of Peripheral Intervention Drug-Eluting Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peripheral Intervention Drug-Eluting Devices Distributors
11.3 Peripheral Intervention Drug-Eluting Devices Customer
12 WORLD FORECAST REVIEW FOR PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES BY GEOGRAPHIC REGION
12.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Forecast by Region
12.1.1 Global Peripheral Intervention Drug-Eluting Devices Forecast by Region (2025-2030)
12.1.2 Global Peripheral Intervention Drug-Eluting Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Peripheral Intervention Drug-Eluting Devices Forecast by Type
12.7 Global Peripheral Intervention Drug-Eluting Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic plc
13.1.1 Medtronic plc Company Information
13.1.2 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic plc Main Business Overview
13.1.5 Medtronic plc Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Cardinal Health
13.4.1 Cardinal Health Company Information
13.4.2 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Cardinal Health Main Business Overview
13.4.5 Cardinal Health Latest Developments
13.5 B. Braun Melsungen AG
13.5.1 B. Braun Melsungen AG Company Information
13.5.2 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 B. Braun Melsungen AG Main Business Overview
13.5.5 B. Braun Melsungen AG Latest Developments
13.6 Biosensors International Group Ltd.
13.6.1 Biosensors International Group Ltd. Company Information
13.6.2 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Biosensors International Group Ltd. Main Business Overview
13.6.5 Biosensors International Group Ltd. Latest Developments
13.7 C.R. Bard, Inc.
13.7.1 C.R. Bard, Inc. Company Information
13.7.2 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 C.R. Bard, Inc. Main Business Overview
13.7.5 C.R. Bard, Inc. Latest Developments
13.8 Abbott
13.8.1 Abbott Company Information
13.8.2 Abbott Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Abbott Main Business Overview
13.8.5 Abbott Latest Developments
13.9 The Lubrizol Corporation
13.9.1 The Lubrizol Corporation Company Information
13.9.2 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 The Lubrizol Corporation Main Business Overview
13.9.5 The Lubrizol Corporation Latest Developments
13.10 Terumo Corporation
13.10.1 Terumo Corporation Company Information
13.10.2 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
13.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Terumo Corporation Main Business Overview
13.10.5 Terumo Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peripheral Intervention Drug-Eluting Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Peripheral Intervention Drug-Eluting Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Drug-Eluting Balloons
Table 4. Major Players of Drug-Eluting Stents
Table 5. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024) & (K Units)
Table 6. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Table 7. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2019-2024) & ($ million)
Table 8. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2019-2024)
Table 9. Global Peripheral Intervention Drug-Eluting Devices Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024) & (K Units)
Table 11. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Table 12. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2019-2024)
Table 13. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2019-2024)
Table 14. Global Peripheral Intervention Drug-Eluting Devices Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Peripheral Intervention Drug-Eluting Devices Sales by Company (2019-2024) & (K Units)
Table 16. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2019-2024)
Table 17. Global Peripheral Intervention Drug-Eluting Devices Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2019-2024)
Table 19. Global Peripheral Intervention Drug-Eluting Devices Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Peripheral Intervention Drug-Eluting Devices Producing Area Distribution and Sales Area
Table 21. Players Peripheral Intervention Drug-Eluting Devices Products Offered
Table 22. Peripheral Intervention Drug-Eluting Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Peripheral Intervention Drug-Eluting Devices Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Geographic Region (2019-2024)
Table 27. Global Peripheral Intervention Drug-Eluting Devices Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Peripheral Intervention Drug-Eluting Devices Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country/Region (2019-2024)
Table 31. Global Peripheral Intervention Drug-Eluting Devices Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
Table 34. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 35. Americas Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 37. Americas Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024) & (K Units)
Table 38. Americas Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024) & (K Units)
Table 39. APAC Peripheral Intervention Drug-Eluting Devices Sales by Region (2019-2024) & (K Units)
Table 40. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2019-2024)
Table 41. APAC Peripheral Intervention Drug-Eluting Devices Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2019-2024)
Table 43. APAC Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024) & (K Units)
Table 44. APAC Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024) & (K Units)
Table 45. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
Table 46. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 47. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 49. Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024) & (K Units)
Table 50. Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Peripheral Intervention Drug-Eluting Devices
Table 58. Key Market Challenges & Risks of Peripheral Intervention Drug-Eluting Devices
Table 59. Key Industry Trends of Peripheral Intervention Drug-Eluting Devices
Table 60. Peripheral Intervention Drug-Eluting Devices Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Peripheral Intervention Drug-Eluting Devices Distributors List
Table 63. Peripheral Intervention Drug-Eluting Devices Customer List
Table 64. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Peripheral Intervention Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Peripheral Intervention Drug-Eluting Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Peripheral Intervention Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Medtronic plc Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 80. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Medtronic plc Main Business
Table 82. Medtronic plc Latest Developments
Table 83. Boston Scientific Corporation Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 84. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 85. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Boston Scientific Corporation Main Business
Table 87. Boston Scientific Corporation Latest Developments
Table 88. Abbott Laboratories Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 90. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Abbott Laboratories Main Business
Table 92. Abbott Laboratories Latest Developments
Table 93. Cardinal Health Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 94. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 95. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Cardinal Health Main Business
Table 97. Cardinal Health Latest Developments
Table 98. B. Braun Melsungen AG Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 99. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 100. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. B. Braun Melsungen AG Main Business
Table 102. B. Braun Melsungen AG Latest Developments
Table 103. Biosensors International Group Ltd. Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 104. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 105. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Biosensors International Group Ltd. Main Business
Table 107. Biosensors International Group Ltd. Latest Developments
Table 108. C.R. Bard, Inc. Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 109. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 110. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. C.R. Bard, Inc. Main Business
Table 112. C.R. Bard, Inc. Latest Developments
Table 113. Abbott Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 114. Abbott Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 115. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Abbott Main Business
Table 117. Abbott Latest Developments
Table 118. The Lubrizol Corporation Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 119. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 120. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. The Lubrizol Corporation Main Business
Table 122. The Lubrizol Corporation Latest Developments
Table 123. Terumo Corporation Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 124. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 125. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Terumo Corporation Main Business
Table 127. Terumo Corporation Latest Developments
Table 1. Peripheral Intervention Drug-Eluting Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Peripheral Intervention Drug-Eluting Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Drug-Eluting Balloons
Table 4. Major Players of Drug-Eluting Stents
Table 5. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024) & (K Units)
Table 6. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Table 7. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2019-2024) & ($ million)
Table 8. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2019-2024)
Table 9. Global Peripheral Intervention Drug-Eluting Devices Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024) & (K Units)
Table 11. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Table 12. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2019-2024)
Table 13. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2019-2024)
Table 14. Global Peripheral Intervention Drug-Eluting Devices Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Peripheral Intervention Drug-Eluting Devices Sales by Company (2019-2024) & (K Units)
Table 16. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2019-2024)
Table 17. Global Peripheral Intervention Drug-Eluting Devices Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2019-2024)
Table 19. Global Peripheral Intervention Drug-Eluting Devices Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Peripheral Intervention Drug-Eluting Devices Producing Area Distribution and Sales Area
Table 21. Players Peripheral Intervention Drug-Eluting Devices Products Offered
Table 22. Peripheral Intervention Drug-Eluting Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Peripheral Intervention Drug-Eluting Devices Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Geographic Region (2019-2024)
Table 27. Global Peripheral Intervention Drug-Eluting Devices Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Peripheral Intervention Drug-Eluting Devices Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country/Region (2019-2024)
Table 31. Global Peripheral Intervention Drug-Eluting Devices Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
Table 34. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 35. Americas Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 37. Americas Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024) & (K Units)
Table 38. Americas Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024) & (K Units)
Table 39. APAC Peripheral Intervention Drug-Eluting Devices Sales by Region (2019-2024) & (K Units)
Table 40. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2019-2024)
Table 41. APAC Peripheral Intervention Drug-Eluting Devices Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2019-2024)
Table 43. APAC Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024) & (K Units)
Table 44. APAC Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024) & (K Units)
Table 45. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
Table 46. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 47. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 49. Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024) & (K Units)
Table 50. Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Peripheral Intervention Drug-Eluting Devices
Table 58. Key Market Challenges & Risks of Peripheral Intervention Drug-Eluting Devices
Table 59. Key Industry Trends of Peripheral Intervention Drug-Eluting Devices
Table 60. Peripheral Intervention Drug-Eluting Devices Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Peripheral Intervention Drug-Eluting Devices Distributors List
Table 63. Peripheral Intervention Drug-Eluting Devices Customer List
Table 64. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Peripheral Intervention Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Peripheral Intervention Drug-Eluting Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Peripheral Intervention Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Medtronic plc Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 80. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Medtronic plc Main Business
Table 82. Medtronic plc Latest Developments
Table 83. Boston Scientific Corporation Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 84. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 85. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Boston Scientific Corporation Main Business
Table 87. Boston Scientific Corporation Latest Developments
Table 88. Abbott Laboratories Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 90. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Abbott Laboratories Main Business
Table 92. Abbott Laboratories Latest Developments
Table 93. Cardinal Health Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 94. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 95. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Cardinal Health Main Business
Table 97. Cardinal Health Latest Developments
Table 98. B. Braun Melsungen AG Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 99. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 100. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. B. Braun Melsungen AG Main Business
Table 102. B. Braun Melsungen AG Latest Developments
Table 103. Biosensors International Group Ltd. Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 104. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 105. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Biosensors International Group Ltd. Main Business
Table 107. Biosensors International Group Ltd. Latest Developments
Table 108. C.R. Bard, Inc. Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 109. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 110. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. C.R. Bard, Inc. Main Business
Table 112. C.R. Bard, Inc. Latest Developments
Table 113. Abbott Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 114. Abbott Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 115. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Abbott Main Business
Table 117. Abbott Latest Developments
Table 118. The Lubrizol Corporation Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 119. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 120. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. The Lubrizol Corporation Main Business
Table 122. The Lubrizol Corporation Latest Developments
Table 123. Terumo Corporation Basic Information, Peripheral Intervention Drug-Eluting Devices Manufacturing Base, Sales Area and Its Competitors
Table 124. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolios and Specifications
Table 125. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Terumo Corporation Main Business
Table 127. Terumo Corporation Latest Developments
LIST OF FIGURES
Figure 1. Picture of Peripheral Intervention Drug-Eluting Devices
Figure 2. Peripheral Intervention Drug-Eluting Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peripheral Intervention Drug-Eluting Devices Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Peripheral Intervention Drug-Eluting Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Drug-Eluting Balloons
Figure 10. Product Picture of Drug-Eluting Stents
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2023
Figure 12. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2019-2024)
Figure 13. Peripheral Intervention Drug-Eluting Devices Consumed in Plain Old Balloon Angioplasty (POBA)
Figure 14. Global Peripheral Intervention Drug-Eluting Devices Market: Plain Old Balloon Angioplasty (POBA) (2019-2024) & (K Units)
Figure 15. Peripheral Intervention Drug-Eluting Devices Consumed in Percutaneous Transluminal Angioplasty (PTA)
Figure 16. Global Peripheral Intervention Drug-Eluting Devices Market: Percutaneous Transluminal Angioplasty (PTA) (2019-2024) & (K Units)
Figure 17. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2023)
Figure 18. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application in 2023
Figure 19. Peripheral Intervention Drug-Eluting Devices Sales Market by Company in 2023 (K Units)
Figure 20. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company in 2023
Figure 21. Peripheral Intervention Drug-Eluting Devices Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company in 2023
Figure 23. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Peripheral Intervention Drug-Eluting Devices Sales 2019-2024 (K Units)
Figure 26. Americas Peripheral Intervention Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 27. APAC Peripheral Intervention Drug-Eluting Devices Sales 2019-2024 (K Units)
Figure 28. APAC Peripheral Intervention Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 29. Europe Peripheral Intervention Drug-Eluting Devices Sales 2019-2024 (K Units)
Figure 30. Europe Peripheral Intervention Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 33. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 34. Americas Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 35. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 36. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 37. United States Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region in 2023
Figure 42. APAC Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions in 2023
Figure 43. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 44. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 45. China Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 53. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 54. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 55. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 56. Germany Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 65. Egypt Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Peripheral Intervention Drug-Eluting Devices in 2023
Figure 71. Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
Figure 72. Industry Chain Structure of Peripheral Intervention Drug-Eluting Devices
Figure 73. Channels of Distribution
Figure 74. Global Peripheral Intervention Drug-Eluting Devices Sales Market Forecast by Region (2025-2030)
Figure 75. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Peripheral Intervention Drug-Eluting Devices
Figure 2. Peripheral Intervention Drug-Eluting Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peripheral Intervention Drug-Eluting Devices Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Peripheral Intervention Drug-Eluting Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Drug-Eluting Balloons
Figure 10. Product Picture of Drug-Eluting Stents
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2023
Figure 12. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2019-2024)
Figure 13. Peripheral Intervention Drug-Eluting Devices Consumed in Plain Old Balloon Angioplasty (POBA)
Figure 14. Global Peripheral Intervention Drug-Eluting Devices Market: Plain Old Balloon Angioplasty (POBA) (2019-2024) & (K Units)
Figure 15. Peripheral Intervention Drug-Eluting Devices Consumed in Percutaneous Transluminal Angioplasty (PTA)
Figure 16. Global Peripheral Intervention Drug-Eluting Devices Market: Percutaneous Transluminal Angioplasty (PTA) (2019-2024) & (K Units)
Figure 17. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2023)
Figure 18. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application in 2023
Figure 19. Peripheral Intervention Drug-Eluting Devices Sales Market by Company in 2023 (K Units)
Figure 20. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company in 2023
Figure 21. Peripheral Intervention Drug-Eluting Devices Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company in 2023
Figure 23. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Peripheral Intervention Drug-Eluting Devices Sales 2019-2024 (K Units)
Figure 26. Americas Peripheral Intervention Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 27. APAC Peripheral Intervention Drug-Eluting Devices Sales 2019-2024 (K Units)
Figure 28. APAC Peripheral Intervention Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 29. Europe Peripheral Intervention Drug-Eluting Devices Sales 2019-2024 (K Units)
Figure 30. Europe Peripheral Intervention Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue 2019-2024 ($ Millions)
Figure 33. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 34. Americas Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 35. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 36. Americas Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 37. United States Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region in 2023
Figure 42. APAC Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions in 2023
Figure 43. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 44. APAC Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 45. China Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 53. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 54. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 55. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 56. Germany Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2024)
Figure 65. Egypt Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Peripheral Intervention Drug-Eluting Devices Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Peripheral Intervention Drug-Eluting Devices in 2023
Figure 71. Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
Figure 72. Industry Chain Structure of Peripheral Intervention Drug-Eluting Devices
Figure 73. Channels of Distribution
Figure 74. Global Peripheral Intervention Drug-Eluting Devices Sales Market Forecast by Region (2025-2030)
Figure 75. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Application (2025-2030)
